Everest Medicines Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Mar 24 | Sell€4,832,305 | CBC Group | Company | 1,468,000 | €3.29 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 3,294,449 | 1.03% |
Institutions | 49,365,143 | 15.4% |
VC/PE Firms | 132,042,877 | 41.3% |
General Public | 135,132,178 | 42.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
132,042,877 | €408.6m | -0.28% | 95.99% | |||
15,875,944 | €49.1m | 0% | 7.95% | |||
15,219,811 | €47.1m | 0% | 0.65% | |||
6,931,053 | €21.4m | 1.17% | no data | |||
3,835,000 | €11.9m | 0.24% | no data | |||
3,047,500 | €9.4m | 33.9% | 0.05% | |||
1,910,000 | €5.9m | -52% | no data | |||
1,136,573 | €3.5m | 1.44% | no data | |||
1,115,000 | €3.5m | 37.2% | 0.07% | |||
980,474 | €3.0m | 13.9% | no data | |||
869,000 | €2.7m | 0% | 0.01% | |||
552,000 | €1.7m | -8.53% | no data | |||
202,589 | €626.9k | 172% | no data | |||
202,470 | €626.5k | 0.17% | no data | |||
172,500 | €533.7k | 0% | no data | |||
160,075 | €495.3k | 0% | no data | |||
156,500 | €484.2k | 27.2% | no data | |||
117,500 | €363.6k | 0% | no data | |||
73,492 | €227.4k | -5.21% | no data | |||
41,311 | €127.9k | 0% | no data | |||
33,000 | €102.1k | 0% | no data | |||
15,300 | €47.3k | 143% | no data | |||
7,500 | €23.2k | 0% | no data | |||
3,500 | €10.8k | 0% | no data | |||
500 | €1.6k | -100% | no data |